Z-ligustilide attenuates lipopolysaccharide-induced proinflammatory response via inhibiting NF-KB pathway in primary rat microglia
Aim: To investigate the anti-inflammatory effect of Z-ligustilide (LIG) on lipopolysaccharide (LPS)-activated primary rat microglia. Methods: Microglia were pretreated with LIG I h prior to stimulation with LPS (1 pg/mL). After 24 h, cell viability was tested with MTT, nitric oxide (NO) production w...
Saved in:
Published in | Acta pharmacologica Sinica no. 7; pp. 791 - 797 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Aim: To investigate the anti-inflammatory effect of Z-ligustilide (LIG) on lipopolysaccharide (LPS)-activated primary rat microglia. Methods: Microglia were pretreated with LIG I h prior to stimulation with LPS (1 pg/mL). After 24 h, cell viability was tested with MTT, nitric oxide (NO) production was assayed with Griess reagent, and the content of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and monocyte chemoattractant protein (MCP-1) was measured with ELISA. Protein expression of the nuclear factor-KB (NF-KB) p65 subunit, cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS) was detected with immunocytochemistry I h or 24 h after LPS treatment. Results: LIG showed a concentration-dependent anti-inflammatory effect in LPS-activated microglia, without causing cytotoxicity. Pretreatment with LIG at 2.5, 5, 10, and 20 pmol/L decreased LPS-induced NO production to 75.9%, 54.4%, 43.1%, and 47.6% (P〈0.05 or P〈0.01), TNF-α content to 86.2%, 68.3%, 40.1%, and 39.9% (P〈0.01, with the exception of 86.2% for 2.5 pmol/L LIG), LI-1β content to 31.5%, 27.7%, 0.6%, and 0% (P〈0.01), and MCP-1 content to 84.4%, 50.3%, 45.1%, and 42.2% (P〈0.05 or P〈0.01), respectively, compared with LPS treatment alone. LIG (10 μmol/L) significantly inhibited LPS-stimulated immunoreactivity of activated NF-KB, COX- 2, and iNOS (P〈0.01 vs LPS group). Conclusion: LIG exerted a potent anti-inflammatory effect on microglia through inhibition of NF-κB pathway. The data provide direct evidence of the neuroprotective effects of LIG and the potential application of LIG for the treatment of the neuroinflammatory diseases characterized by excessive microglial activation. |
---|---|
Bibliography: | cyclooxygenase-2 Z-ligustilide (LIG) Z-ligustilide (LIG); microglia; neuroinflammation; lipopolysaccharide; NF-κB; tumor necrosis factor-o; interleukin-1β; iNOS;cyclooxygenase-2 interleukin-1β 31-1347/R NF-κB tumor necrosis factor-o neuroinflammation S942.5 Q813.11 iNOS lipopolysaccharide microglia |
ISSN: | 1671-4083 1745-7254 |